Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 2Withdrawn 1Terminated 1Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Leukemia, Myeloid, Acute 1Febrile Neutropenia 1

Interventions

Peripheral Blood Stem Cell Transplantation 4fludarabine phosphate 2Whole-Body Irradiation 2Methotrexate 2Cyclosporine 2Cyclophosphamide 2Busulfan 2siltuximab 1pegylated granulocyte colony-stimulating factor 1magrolimab 1hetrombopag 1fludarabine 1ferric gluconate 1decitabine and cedazuridine drug combination 1ceftolozane, tazobactam drug combination 1avatrombopag 1Transplantation 1Tacrolimus 1Radiotherapy 1Pluvicto 1Pentostatin 1Mycophenolic Acid 1Micafungin 1Meropenem 1Iron-Dextran Complex 1Iron 1In Situ Hybridization, Fluorescence 1Immunoenzyme Techniques 1Holistic Health 1Genotype 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Meropenem × Classical hematology × Clear all
NCT05784844 2024-09-19

Antimicrobial Revision in Persistent Febrile Neutropenia

Wake Forest University Health Sciences

Phase 4 Withdrawn
Classical hematologyLymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡